Rich Adcock

Richard (Rich) Adcock was named Chief Executive Officer of ImmunityBio in January 2021. Formerly CEO of NantKwest, he has held leadership positions in healthcare for nearly 30 years and is recognized for his expertise in building cultures focused on rapid, strategic innovation. He is a Six Sigma Master Black Belt, ensuring that the execution of those strategies is accompanied by strong quality systems throughout the enterprise. Previously, Adcock was CEO of Verity Health, where he led a successful restructuring event. He began his career in 1992 as a co-founder and Vice President of Research and Development for Micro Medical Systems, pioneering the development of early Cardiology Electronic Medical Records. Adcock assumed leadership roles in healthcare innovation following the company’s acquisition by GE Healthcare in 1999. He subsequently earned an MBA in Healthcare Management and joined Sanford Health where he served as President and later as Chief Innovation Officer.